UBS Group’s ProAssurance PRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-420,751
| Closed | -$10.4M | – | 10905 |
|
|
2026
Q1 | $10.4M | Buy |
420,751
+58,464
| +16% | +$1.43M | ﹤0.01% | 3293 |
|
|
2025
Q4 | $8.75M | Sell |
362,287
-253,789
| -41% | -$6.1M | ﹤0.01% | 3432 |
|
|
2025
Q3 | $14.8M | Buy |
616,076
+148,979
| +32% | +$3.55M | ﹤0.01% | 2893 |
|
|
2025
Q2 | $10.7M | Buy |
467,097
+284,557
| +156% | +$6.57M | ﹤0.01% | 3024 |
|
|
2025
Q1 | $4.26M | Sell |
182,540
-63,362
| -26% | -$1.03M | ﹤0.01% | 3954 |
|
|
2024
Q4 | $3.91M | Buy |
245,902
+127,159
| +107% | +$2.02M | ﹤0.01% | 4094 |
|
|
2024
Q3 | $1.79M | Buy |
118,743
+68,477
| +136% | +$874K | ﹤0.01% | 4114 |
|
|
2024
Q2 | $614K | Sell |
50,266
-4,621
| -8% | -$62.7K | ﹤0.01% | 4843 |
|
|
2024
Q1 | $706K | Buy |
54,887
+1,276
| +2% | +$16.4K | ﹤0.01% | 4909 |
|
|
2023
Q4 | $739K | Buy |
53,611
+34,128
| +175% | +$522K | ﹤0.01% | 4757 |
|
|
2023
Q3 | $368K | Sell |
19,483
-49,886
| -72% | -$864K | ﹤0.01% | 4894 |
|
|
2023
Q2 | $1.05M | Buy |
69,369
+10,443
| +18% | +$164K | ﹤0.01% | 4200 |
|
|
2023
Q1 | $1.09M | Buy |
58,926
+7,161
| +14% | +$135K | ﹤0.01% | 4031 |
|
|
2022
Q4 | $904K | Buy |
51,765
+30,203
| +140% | +$595K | ﹤0.01% | 4168 |
|
|
2022
Q3 | $420K | Buy |
21,562
+21,278
| +7,492% | +$467K | ﹤0.01% | 4498 |
|
|
2022
Q2 | $7K | Sell |
284
-23,436
| -99% | -$550K | ﹤0.01% | 8515 |
|
|
2022
Q1 | $638K | Buy |
23,720
+2,770
| +13% | +$68.5K | ﹤0.01% | 4504 |
|
|
2021
Q4 | $530K | Buy |
20,950
+13,360
| +176% | +$319K | ﹤0.01% | 4933 |
|
|
2021
Q3 | $181K | Sell |
7,590
-20,421
| -73% | -$470K | ﹤0.01% | 5391 |
|
|
2021
Q2 | $638K | Sell |
28,011
-29,368
| -51% | -$739K | ﹤0.01% | 4543 |
|
|
2021
Q1 | $1.54M | Sell |
57,379
-60,991
| -52% | -$1.41M | ﹤0.01% | 3828 |
|
|
2020
Q4 | $2.11M | Buy |
118,370
+12,590
| +12% | +$205K | ﹤0.01% | 3361 |
|
|
2020
Q3 | $1.65M | Buy |
105,780
+39,655
| +60% | +$590K | ﹤0.01% | 3230 |
|
|
2020
Q2 | $957K | Buy |
66,125
+30,936
| +88% | +$531K | ﹤0.01% | 3547 |
|
|
2020
Q1 | $880K | Sell |
35,189
-49,319
| -58% | -$1.49M | ﹤0.01% | 3463 |
|
|
2019
Q4 | $3.05M | Buy |
84,508
+31,524
| +59% | +$1.21M | ﹤0.01% | 3113 |
|
|
2019
Q3 | $2.13M | Buy |
52,984
+28,824
| +119% | +$1.12M | ﹤0.01% | 3225 |
|
|
2019
Q2 | $872K | Sell |
24,160
-15,520
| -39% | -$577K | ﹤0.01% | 3859 |
|
|
2019
Q1 | $1.37M | Buy |
39,680
+1,420
| +4% | +$57.5K | ﹤0.01% | 3321 |
|
|
2018
Q4 | $1.55M | Sell |
38,260
-2,394
| -6% | -$103K | ﹤0.01% | 3285 |
|
|
2018
Q3 | $1.91M | Buy |
40,654
+1,708
| +4% | +$75.1K | ﹤0.01% | 3257 |
|
|
2018
Q2 | $1.38M | Sell |
38,946
-10,989
| -22% | -$459K | ﹤0.01% | 3494 |
|
|
2018
Q1 | $2.42M | Buy |
49,935
+1,527
| +3% | +$79.3K | ﹤0.01% | 2974 |
|
|
2017
Q4 | $2.77M | Buy |
48,408
+8,472
| +21% | +$494K | ﹤0.01% | 2902 |
|
|
2017
Q3 | $2.18M | Buy |
39,936
+3,390
| +9% | +$192K | ﹤0.01% | 3055 |
|
|
2017
Q2 | $2.22M | Sell |
36,546
-2,238
| -6% | -$134K | ﹤0.01% | 2924 |
|
|
2017
Q1 | $2.34M | Sell |
38,784
-1,445
| -4% | -$82.9K | ﹤0.01% | 2811 |
|
|
2016
Q4 | $2.26M | Buy |
40,229
+767
| +2% | +$42.5K | ﹤0.01% | 2811 |
|
|
2016
Q3 | $2.07M | Buy |
39,462
+503
| +1% | +$26.7K | ﹤0.01% | 2810 |
|
|
2016
Q2 | $2.09M | Sell |
38,959
-1,291
| -3% | -$64.7K | ﹤0.01% | 2743 |
|
|
2016
Q1 | $2.04M | Buy |
40,250
+1,812
| +5% | +$89.4K | ﹤0.01% | 2661 |
|
|
2015
Q4 | $1.86M | Sell |
38,438
-1,106
| -3% | -$56.8K | ﹤0.01% | 2856 |
|
|
2015
Q3 | $1.94M | Sell |
39,544
-11,419
| -22% | -$555K | ﹤0.01% | 2771 |
|
|
2015
Q2 | $2.35M | Sell |
50,963
-911
| -2% | -$41.4K | ﹤0.01% | 2818 |
|
|
2015
Q1 | $2.38M | Buy |
51,874
+8,488
| +20% | +$386K | ﹤0.01% | 2773 |
|
|
2014
Q4 | $1.96M | Buy |
+43,386
| New | +$1.98M | ﹤0.01% | 2925 |
|
Other funds holding PRA
UBS Group's PRA Position: Q2 2026 in Review
UBS Group sold out of ProAssurance (PRA) in Q2 2026, closing a stake of 420,751 shares — an estimated $10.4M sold.
UBS Group first reported a position in PRA in Q4 2014 and held it in 46 quarters. The position peaked at $14.8M in Q3 2025. 2 funds tracked by Wall St. Rank hold PRA as of Q2 2026.
- UBS Group reported no remaining ProAssurance position as of Q2 2026 after selling out during the quarter.
- UBS Group sold 420,751 ProAssurance shares in Q2 2026, an estimated $10.4M.
- UBS Group first reported a position in ProAssurance in Q4 2014 and held it in 46 quarters.
- UBS Group's ProAssurance position peaked at $14.8M in Q3 2025.
- 2 funds tracked by Wall St. Rank held ProAssurance as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.